Practical considerations to implement the shorter regimen to MDR-TB patients in China

被引：3
|
作者：
Liu, Q. [1 ]
Sun, F. [1 ]
Li, Y. [1 ]
Bao, J. [2 ]
Zhang, Y. [1 ,3 ]
Zhang, W. [1 ]
机构：
[1] Fudan Univ, Huashan Hosp, Dept Infect Dis, 12 WulumuqiZhong Rd, Shanghai 200040, Peoples R China
[2] NIAID, TB Clin Res Branch, Div AIDS, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2018年 / 24卷 / 10期
关键词：
MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; BENEFIT; EUROPE;
D O I：
10.1016/j.cmi.2018.04.026
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1035 / 1036
页数：2
相关论文
共 50 条
  • [1] Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?
    Dheda, Keertan
    Cox, Helen
    Esmail, Aliasgar
    Wasserman, Sean
    Chang, Kwok Chiu
    Lange, Christoph
    RESPIROLOGY, 2018, 23 (01) : 36 - 45
  • [2] Personalized medicine for patients with MDR-TB
    Olaru, Ioana D.
    Lange, Christoph
    Heyckendorf, Jan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (04) : 852 - 855
  • [3] Factors affecting the treatment outcome of injection based shorter MDR-TB regimen at a referral centre in India
    Kiran, B.
    Singla, Rupak
    Singla, Neeta
    Vinay, V.
    Singh, Kuljeet
    Choudhury, Madhumita Paul
    Bhattacherjee, Nilotpal
    MONALDI ARCHIVES FOR CHEST DISEASE, 2023, 93 (03)
  • [4] Prospective study on outcome of MDR-TB using the shorter regimen during COVID-19 pandemic
    Kumar, Sravan G.
    Sameena, P.
    Karthik, V
    Ghanate, Nalini
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2023, 12 (06) : 1087 - 1091
  • [5] High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon
    Kuaban, C.
    Noeske, J.
    Rieder, H. L.
    Ait-Khaled, N.
    Foe, J. L. Abena
    Trebucq, A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (05) : 517 - 524
  • [6] The affordability for patients of a new universal MDR-TB coverage model in China
    Ruan, Y-Z.
    Li, R-Z.
    Wang, X-X.
    Wang, L-X.
    Sun, Q.
    Chen, C.
    Xu, C-H.
    Su, W.
    Zhao, J.
    Pang, Y.
    Cheng, J.
    Wang, Q.
    Fu, Y-T.
    Huan, S-T.
    Chen, M-T.
    Scano, F.
    Floyd, K.
    Chin, D. P.
    Fitzpatrick, C.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (05) : 638 - 644
  • [7] Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar
    Wai, Pyae Phyo
    Shewade, Hemant Deepak
    Kyaw, Nang Thu Thu
    Thein, Saw
    Thu, Aung Si
    Kyaw, Khine Wut Yee
    Aye, Nyein Nyein
    Phyo, Aye Mon
    Maung, Htet Myet Win
    Soe, Kyaw Thu
    Aung, Si Thu
    PLOS ONE, 2018, 13 (03):
  • [8] Methodological considerations in clinical trials for new MDR-TB treatment regimens
    Phillips, P. P. J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (12) : S4 - S7
  • [9] Nurses as providers of emotional support to patients with MDR-TB
    Chalco, K.
    Wu, D. Y.
    Mestanza, L.
    Munoz, M.
    Llaro, K.
    Guerra, D.
    Palacios, E.
    Furin, J.
    Shin, S.
    Sapag, R.
    INTERNATIONAL NURSING REVIEW, 2006, 53 (04) : 253 - 260
  • [10] Prevalence of hypothyroidism among MDR-TB patients in Botswana
    Modongo, Chawangwa
    Zetola, Nicola M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (11) : 1561 - 1562
12345